AKT1 and breast cancer: The activation/deregulation of the PI3K/Akt/mTOR pathway is frequent in BC (20%–40%) and is a significant cause of aggressive tumor behavior, as well as treatment resistance, and plays a crucial role in cell viability and propagation [143].